Sphygmocor XCEL the device they are selling to the clinical practice market is priced at 14,000 US , all its competitors are priced much lower . Do you see clinical practices buying the most expensive unit. The lowest competitor is 1/3 the cost of XCEL and will also have the CPT 1 code early next year they mention. ACG currently priced at $46m mainly because one investor bought up and has now gone conspicuously under 5% holding. I do hope the sales turn up and will be waiting for confirmation.
Ann: App 4E / Full Year Statutory Accounts, page-7
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
